Didanosine Oral Solution and Promacta (Eltrombopag Powder for Suspension)
Determining the interaction of Didanosine Oral Solution and Promacta (Eltrombopag Powder for Suspension) and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this interaction is not currently available.ADJUST DOSING INTERVAL: Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly reduce the gastrointestinal absorption of eltrombopag due to chelation. In one clinical trial, administration of a single 75 mg dose of eltrombopag with an antacid containing 1524 mg aluminum hydroxide and 1425 mg magnesium carbonate resulted in an approximately 70% decrease in eltrombopag peak plasma concentration (Cmax) and systemic exposure (AUC). MANAGEMENT: Eltrombopag should be taken on an empty stomach at least 2 hours before or 4 hours after oral medications that contain antacids (e.g., didanosine buffered tablets or pediatric oral solution), aluminum, calcium, iron, magnesium, zinc or other polyvalent cations. References Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 "Product Information. Promacta (eltrombopag)." GlaxoSmithKline, Research Triangle Park, NC.
Professional:ADJUST DOSING INTERVAL: Products containing aluminum, calcium, iron, magnesium, zinc and other polyvalent cations such as antacids or mineral supplements can significantly reduce the gastrointestinal absorption of eltrombopag due to chelation. In one clinical trial, administration of a single 75 mg dose of eltrombopag with an antacid containing 1524 mg aluminum hydroxide and 1425 mg magnesium carbonate resulted in an approximately 70% decrease in eltrombopag peak plasma concentration (Cmax) and systemic exposure (AUC).
MANAGEMENT: Eltrombopag should be taken on an empty stomach at least 2 hours before or 4 hours after oral medications that contain antacids (e.g., didanosine buffered tablets or pediatric oral solution), aluminum, calcium, iron, magnesium, zinc or other polyvalent cations.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- "Product Information. Promacta (eltrombopag)." GlaxoSmithKline, Research Triangle Park, NC.
Generic Name: didanosine
Brand name: Videx, Videx EC
Synonyms: Didanosine
Generic Name: eltrombopag
Brand name: Promacta
Synonyms: Promacta
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Didanosine Oral Solution-Promacta (Eltrombopag Tablets)
- Didanosine Oral Solution-Promethazine
- Didanosine Oral Solution-Promethazine and Phenylephrine
- Didanosine Oral Solution-Promethazine Hydrochloride
- Didanosine Oral Solution-Promethazine injection
- Didanosine Oral Solution-Promethazine Injection, Intravenous
- Promacta (Eltrombopag Powder for Suspension)-Didanosine Tablet, for suspension
- Promacta (Eltrombopag Powder for Suspension)-Didrex
- Promacta (Eltrombopag Powder for Suspension)-Didronel
- Promacta (Eltrombopag Powder for Suspension)-Dienogest and estradiol
- Promacta (Eltrombopag Powder for Suspension)-Diethylene Triamine Penta-Acetic Acid
- Promacta (Eltrombopag Powder for Suspension)-Diethylpropion